BioSig Technologies, Inc. Common StockBSGM
About: BioSig Technologies Inc is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The PURE EP Platform enables electrophysiologists to acquire raw signal data in real-time, absent unnecessary noise or interference, to maximize procedural success and minimize unnecessary inefficiencies.
Employees: 5
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
800% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 1
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
8% more funds holding
Funds holding: 26 [Q4 2024] → 28 (+2) [Q1 2025]
13.62% less ownership
Funds ownership: 46.41% [Q4 2024] → 32.79% (-13.62%) [Q1 2025]
39% less capital invested
Capital invested by funds: $7.73M [Q4 2024] → $4.69M (-$3.04M) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Ascendiant Capital Edward Woo | 56%upside $10 | Buy Maintained | 6 Jun 2025 |
Financial journalist opinion
Based on 8 articles about BSGM published over the past 30 days









